At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Self Administered CBT for IBS: A Multisite Trial
In Brief
A clinical study evaluating Self Administered Cognitive Behavior Therapy, Therapist Administered Cognitive Behavior Therapy, and 1 other intervention for Irritable Bowel Syndrome. Completed, enrolled 436 participants across 2 sites.
Detailed Summary
The primary goal of the proposed trial is to assess the short- and long-term efficacy of cognitive behavior therapy (CBT) for irritable bowel syndrome using two treatment delivery systems (self administered, therapist administered). Secondary aims seek to specify the conditions under which CBT may (or may not) achieve its effects (moderator questions), why and how these effects are achieved (mediator questions) and at what economic cost. Long term project goals are to develop an effective self-administered behavioral treatment program that can enhance the quality of patient care, improve clinical outcomes, and decrease the economic and personal costs of one of the most prevalent and intractable GI disorders.
Study Details
Timeline
Interventions
This 4 session treatment is aimed at controlling symptoms by changing specific behaviors found to aggravate IBS
This 10 session treatment is aimed at controlling symptoms by changing specific behaviors found to aggravate IBS
This 4 session treatment aims at controlling symptoms through support and the provision of information about IBS symptoms, how it is diagnosed, its causes, and treatment options and a collaborative, relationship between the patient and doctor